Mammary Cell News Volume 15.02 | Jan 19 2023

    0
    57








    2023-01-19 | MCN 15.02


    Mammary Cell News by STEMCELL Technologies
    Vol. 15.02 – 19 January, 2023
    TOP STORY

    Niche Stiffness Sustains Cancer Stemness via TAZ and NANOG Phase Separation

    Using clinical-practice ultrasound elastography for patients’ lesions and atomic force microscopy for surgical samples, scientists showed that increased matrix stiffness was linked with poor responses to neoadjuvant chemotherapy, worse prognosis, and cancer stem cell enrichment in patients with breast cancer.
    [Nature
    Communications]

    Full Article
    Explore Antibodies for Epithelial Cell Markers
    PUBLICATIONSRanked by the impact factor of the journal

    HER2-Driven Breast Cancer Suppression by the JNK Signaling Pathway

    Researchers reported that in vitro studies of human mammary epithelial cells with CRISPR-induced mutations in the MAPK and MAP2K components of the JNK pathway had no change in growth in two-dimensional (2D) culture, but promoted epithelial cell proliferation in three-dimensional (3D) culture.
    [Proceedings Of The National Academy Of Sciences Of The United States Of America]

    Full Article

    Tyrosine Kinase SRC-Induced YAP1-KLF5 Module Regulates Cancer Stemness and Metastasis in Triple-Negative Breast Cancer

    Investigators identified a YAP1 tyrosine phosphorylation-dependent YAP1-KLF5 oncogenic module, as the key downstream mediator of SRC kinase regulating cancer stemness and metastasis in TNBC.
    [Cellular And Molecular Life Sciences]

    Full Article

    Basal-Like Mammary Carcinomas Stimulate Cancer Stem Cell Properties through AXL-Signaling to Induce Chemotherapy Resistance

    The authors leveraged the WAP-T syngeneic mammary carcinoma mouse model and developed a strategy combining magnetic-activated cell sorting-based tumor cell enrichment with high-throughput transcriptome analyses.
    [International Journal of Cancer]

    Abstract

    The FOXO1 Inhibitor AS1842856 Triggers Apoptosis in Glioblastoma Multiforme and Basal-Like Breast Cancer Cells

    Given the critical role of cancer stem cells in promoting cancer progression, scientists examined the impact of forkhead box transcription factor 1 (FOXO1) inhibition with AS1842856 on basal-like breast cancer and glioblastoma multiforme cell viability.
    [FEBS Open Bio]

    Full Article

    Aberrant Promoter Hypermethylation of miR-335 and miR-145 Is Involved in Breast Cancer PD-L1 Overexpression

    Investigators studied the role of miR-335 and -145 on programmed cell death 1 receptor-ligand (PD-L1) suppression in breast cancer.
    [Scientific Reports]

    Full Article

    Breast Tumor Metastasis Following Filgrastim Administration Due to the SDF-1/CXCR4 Pathway

    Researchers investigated in vitro and in vivo effects of filgrastim on cell migration, invasion, and metastasis. A lentivirus vector of the anti- C-X-C chemokine receptor type 4 (CXCR4) receptor was first used for the CXCR4 knockout.
    [Medical Oncology]

    AbstractGraphical Abstract

    Evaluation of Poly (Lactic-Co-Glycolic Acid) Nanoparticles to Improve the Therapeutic Efficacy of Paclitaxel in Breast Cancer

    PLGA-PTX nanoparticles were assayed in breast cancer cell lines, breast cancer stem cells, and multicellular tumor spheroids analyzing cell cycle, cell uptake, and α-tubulin expression.
    [Bioimpacts]

    Abstract

    CMTM6 Overexpression Confers Trastuzumab Resistance in HER2-Positive Breast Cancer

    Scientists uncovered a role of CKLF-like MARVEL transmembrane domain-containing 6 (CMTM6) in trastuzumab-resistant HER2+ breast cancer. CMTM6 expression was upregulated in trastuzumab-resistant HER2+ breast cancer cells.
    [Molecular Cancer]

    Full Article
    Five tips for returning to the lab after time off
    REVIEWS

    Breast Cancer and Neurotransmitters: Emerging Insights on Mechanisms and Therapeutic Directions

    The authors discuss neurotransmitters in the context of breast cancer as well as the risk factors, pharmaceuticals impacting neurotransmitter pathways, and the opportunity for better-integrated models that encompass exercise, the intestinal microbiome, and other non-pharmacologic considerations.
    [Oncogene]

    Full Article
    INDUSTRY AND POLICY NEWS

    Ullman Family Team Science Award to Support Novel Breast Cancer Research

    Seven researchers from diverse scientific backgrounds won the Ullman Family Team Science Award for a proposal to investigate novel therapies for TNBC, an aggressive, hard-to-treat form of the disease.
    [University of Chicago Medicine]

    Press Release

    Minerva Biotechnologies Gets FDA Approval of IND for a MUC1*-CAR-1XX with Increased Persistence and Ability to Kill Low Antigen Expressing Cells for Treatment of Solid Tumor Cancers

    Minerva Biotechnologies announced that the FDA has approved their Investigational New Drug (IND) application to conduct clinical trials with huMNC2-CAR22, aka MUC1*-CAR-1XX, for the treatment of metastatic breast cancers.
    [Minerva Biotechnologies (Business Wire)]

    Press Release
    FEATURED EVENT

    AACR Annual Meeting 2023

    April 14 – 19, 2023
    Orlando, Florida, United States

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Training Fellow – Cancer Bioinformatics

    Institute of Cancer Research – London, England, United Kingdom

    Postdoctoral Position – Spatial Omics Analysis

    European Molecular Biology Laboratory – Heidelberg, Germany

    Directors of Clinical Research Programs – Cancer Biology

    IRCCS Candiolo Cancer Institute – Turin, Italy

    Group Leader – Cell Biology

    Pompeu Fabra University – Barcelona, Spain

    Research Scientist – Cancer Molecular Imaging

    Stanford Medicine – Stanford, California, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Mammary Cell News Twitter